Description

DIAMICRON XR 60MG (1X14)

Indications

DIAMICRON XR 60MG is indicated for the management of type 2 diabetes mellitus in adults. It is particularly useful in patients who are not adequately controlled by diet and exercise alone. This medication can be prescribed as monotherapy or in combination with other antidiabetic agents, including insulin, to help achieve optimal glycemic control.

Mechanism of Action

DIAMICRON XR contains the active ingredient gliclazide, which is classified as a sulfonylurea. The primary mechanism of action involves stimulating the pancreatic beta cells to release insulin in response to elevated blood glucose levels. This insulin secretion is glucose-dependent, meaning that it occurs primarily when blood glucose levels are high, thus minimizing the risk of hypoglycemia. Additionally, gliclazide has been shown to improve insulin sensitivity and reduce hepatic glucose production, further contributing to its antidiabetic effects.

Pharmacological Properties

Gliclazide is rapidly absorbed after oral administration, with peak plasma concentrations occurring approximately 6-12 hours post-dose. The extended-release formulation of DIAMICRON XR allows for a sustained release of the active ingredient, providing a prolonged duration of action that supports once-daily dosing. The elimination half-life of gliclazide is approximately 10-12 hours, and it is primarily metabolized by the liver, with excretion occurring via urine. This pharmacokinetic profile makes DIAMICRON XR suitable for once-daily administration, enhancing patient compliance.

Contraindications

DIAMICRON XR is contraindicated in patients with a known hypersensitivity to gliclazide or any of the excipients in the formulation. It should not be used in individuals with type 1 diabetes mellitus or diabetic ketoacidosis, as these conditions require different management strategies. Additionally, the use of DIAMICRON XR is contraindicated in patients with severe renal or hepatic impairment, as the drug’s metabolism and excretion may be significantly affected in these populations.

Side Effects

Common side effects associated with DIAMICRON XR include hypoglycemia, which may manifest as dizziness, sweating, confusion, and palpitations. Other potential side effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Rare but serious adverse effects can include allergic reactions, liver enzyme elevations, and blood dyscrasias. Patients should be monitored regularly for any signs of adverse reactions, especially during the initiation of therapy or when adjusting the dosage.

Dosage and Administration

The recommended starting dose of DIAMICRON XR is typically 30mg once daily, taken with the first meal of the day. Depending on the individual patient’s response and blood glucose levels, the dose may be gradually increased to a maximum of 60mg once daily. It is essential for patients to adhere to the prescribed dosing schedule and to not exceed the maximum recommended dose without consulting a healthcare provider. If a dose is missed, patients should take it as soon as they remember, but should not double up on doses to make up for a missed one.

Interactions

DIAMICRON XR may interact with various medications, potentially altering its effectiveness or increasing the risk of adverse effects. Concomitant use of other antidiabetic agents, such as insulin or other sulfonylureas, may enhance the risk of hypoglycemia. Additionally, drugs that affect hepatic enzymes, such as certain antifungals, antibiotics, and antiepileptics, may influence gliclazide metabolism. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and supplements, to avoid potential interactions.

Precautions

Patients using DIAMICRON XR should be monitored closely for signs of hypoglycemia, particularly during the initial treatment period or when adjusting the dosage. It is crucial for patients to be educated on recognizing the symptoms of low blood sugar and the appropriate actions to take in such situations. Caution is advised when prescribing DIAMICRON XR to elderly patients or those with renal or hepatic impairment, as they may be at increased risk for adverse effects. Regular monitoring of blood glucose levels and periodic assessments of renal and liver function are recommended to ensure safe and effective use of this medication.

Clinical Studies

Clinical studies have demonstrated the efficacy of DIAMICRON XR in improving glycemic control in patients with type 2 diabetes. In randomized controlled trials, patients treated with gliclazide showed significant reductions in HbA1c levels compared to placebo. The extended-release formulation has been associated with improved patient adherence due to its convenient once-daily dosing schedule. Moreover, studies have indicated that gliclazide may have beneficial effects on cardiovascular outcomes, making it a suitable choice for patients with comorbid conditions.

Conclusion

DIAMICRON XR 60MG is a valuable therapeutic option for individuals with type 2 diabetes mellitus, offering effective glycemic control with a favorable safety profile. Its mechanism of action, pharmacological properties, and clinical efficacy make it a cornerstone in the management of this chronic condition. However, careful consideration of contraindications, potential side effects, and drug interactions is essential for optimizing patient outcomes. Ongoing monitoring and patient education are critical components of successful diabetes management with DIAMICRON XR.